Qube Research & Technologies (QRT)
SGMT icon

Qube Research & Technologies (QRT)’s Sagimet Biosciences SGMT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-182,738
Closed -$955K – 4007
2026
Q1 		$955K Buy
182,738
+71,389
+64% +$398K ﹤0.01% 2515
2025
Q4 		$659K Buy
111,349
+4,503
+4% +$32.4K ﹤0.01% 2714
2025
Q3 		$733K Buy
+106,846
New +$866K ﹤0.01% 2616
2025
Q2 		– Sell
-34,184
Closed -$111K – 3926
2025
Q1 		$111K Buy
34,184
+16,243
+91% +$68.1K ﹤0.01% 2989
2024
Q4 		$80.7K Buy
+17,941
New +$90.9K ﹤0.01% 3028
2024
Q1 		– Sell
-1,247
Closed -$6.76K – 4834
2023
Q4 		$6.76K Buy
+1,247
New +$5.88K ﹤0.01% 3669

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SGMT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Sagimet Biosciences (SGMT) in Q2 2026, closing a stake of 182,738 shares — an estimated $955K sold.

Qube Research & Technologies (QRT) first reported a position in SGMT in Q4 2023 and held it in 6 quarters. The position peaked at $955K in Q1 2026. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Sagimet Biosciences position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 182,738 Sagimet Biosciences shares in Q2 2026, an estimated $955K.
  • Qube Research & Technologies (QRT) first reported a position in Sagimet Biosciences in Q4 2023 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Sagimet Biosciences position peaked at $955K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.